Skip to content

BioAdaptives Inc.: 10-Q filed 2022-11-14

What BioAdaptives Inc. reported in its quarterly report filed 2022-11-14 (fiscal Q3 2022): 28 published measures, 86 facts as tagged in accession 0001640334-22-002451.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-14
Fiscal period
fiscal Q3 2022
Accession
0001640334-22-002451 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioAdaptives Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-3029,615USD
At 2021-12-31148,585USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-301,625,473USD
At 2021-12-311,241,624USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-30-1,595,858USD
At 2022-06-30-1,494,946USD
At 2022-03-31-1,398,153USD
At 2021-12-31-1,093,039USD
At 2021-09-30-1,212,286USD
At 2021-06-30-1,351,922USD
At 2021-03-31-1,042,676USD
At 2020-12-31-1,378,785USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-09-3017,909USD
At 2021-12-3182,936USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-276,325USD92
2022-01-01 to 2022-09-30-867,293USD273
2022-04-01 to 2022-06-30-223,837USD91
2022-01-01 to 2022-03-31-367,131USD90
2021-07-01 to 2021-09-30-34,516USD92
2021-01-01 to 2021-09-30-835,665USD273
2021-04-01 to 2021-06-30-309,246USD91
2021-01-01 to 2021-03-31-491,903USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-199,755USD273
2021-01-01 to 2021-09-30-123,248USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-07-01 to 2022-09-303,337USD92
2022-01-01 to 2022-09-3013,192USD273
2021-07-01 to 2021-09-305,342USD92
2021-01-01 to 2021-09-3015,925USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-30134,728USD273
2021-01-01 to 2021-09-30185,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-7,523,402USD
At 2021-12-31-6,656,109USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-07-01 to 2022-09-300USD92
2022-01-01 to 2022-09-300USD273
2021-07-01 to 2021-09-300USD92
2021-01-01 to 2021-09-30163,900USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-3025,941USD
At 2021-12-3188,876USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-07-01 to 2022-09-3094,106USD92
2022-01-01 to 2022-09-30199,572USD273
2021-07-01 to 2021-09-3064,543USD92
2021-01-01 to 2021-09-30141,792USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-301,625,473USD
At 2021-12-311,241,624USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-09-305,340USD
At 2021-12-311,750USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-3079,045USD92
2022-01-01 to 2022-09-30400,694USD273
2021-07-01 to 2021-09-30175,968USD92
2021-01-01 to 2021-09-30467,310USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-09-308,000USD
At 2021-12-314,750USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-302,000USD92
2022-01-01 to 2022-09-306,096USD273
2021-07-01 to 2021-09-303,115USD92
2021-01-01 to 2021-09-308,963USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,337USD92
2022-01-01 to 2022-09-307,096USD273
2021-07-01 to 2021-09-302,227USD92
2021-01-01 to 2021-09-306,962USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-3050,819,780shares
At 2021-12-3150,819,780shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-09-3017,909USD
At 2021-12-3182,936USD
At 2021-09-3066,339USD
At 2020-12-314,587USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-305,914,090USD
At 2021-12-315,557,828USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-302,622USD
At 2021-12-3110,993USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-3043,981USD92
2022-01-01 to 2022-09-30236,698USD273
2021-07-01 to 2021-09-30110,456USD92
2021-01-01 to 2021-09-30152,776USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-01-01 to 2022-09-3059,709USD273
2021-01-01 to 2021-09-3047,500USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-199,280USD92
2022-01-01 to 2022-09-30-472,695USD273
2021-07-01 to 2021-09-30138,337USD92
2021-01-01 to 2021-09-30-377,318USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-304,728USD273
2021-01-01 to 2021-09-3016,424USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-09-300USD273
2021-01-01 to 2021-09-300USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-3,250USD273
2021-01-01 to 2021-09-304,214USD273

Inspect the source

Entity
BioAdaptives Inc. / CIK 0001575142
Captured
2026-09-20T09:21:44.555Z
SEC response SHA-256
7d70ec2a8370eeb33cd7c2482065b30cf052619c39bb59e21df838c8d2f96db2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))